02 Aug

WASHINGTON (August 2, 2019) — Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University (GW) Cancer Center, the GW Cancer Center was selected as...


30 Jul

WASHINGTON, D.C. (July 30, 2019) – Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University (GW) and the GW Cancer Center today announced that Carla J. Berg, PhD, MBA, has been named the associate center...


24 Jul

A research team led by Yanfen Hu, PhD, professor of anatomy and cell biology at the George Washington University (GW)...


09 Jul

WASHINGTON (July 9, 2019) — Sun safety practices for attendees at skin cancer screening events differ from the general public, according to findings published by researchers from the George Washington University (GW) Cancer Center. The study was published in the Journal of Drugs in Dermatology...


13 May

WASHINGTON (May 13, 2019) — The George Washington University (GW) Cancer Center is pleased to announce the establishment of the Dr. Cyrus Katzen Family Director of the GW Cancer Center, thanks to a generous gift from GW alumnus and former Board of Trustee member, ...


22 Apr

In the last 25 years, significant progress has been made in the fight against cancer. Even still, cancer remains the second most common cause of death in the United States, according to the U.S. Centers for Disease Control and Prevention — and those in the D.C. area are not immune to its burden. In fact, the Washington region has some of the highest rates of liver and colon cancer-related deaths in the country.

A few years ago, the George Washington University (GW) opened a state-of-the-art cancer center on its D.C. campus to advance cancer research, patient care and community outreach. Three of the GW Cancer Center's experts recently stopped by WTOP to discuss their approach to caring for patients and the unique benefits of being treated at an academic medical center.


27 Mar

WASHINGTON (March 27, 2019) – Principal Investigator Mandi Pratt-Chapman, MA has been awarded a $4.125 million cooperative agreement to continue work with the Centers for Disease Control and Prevention (CDC) to provide comprehensive technical assistance for National Comprehensive Cancer Control...


18 Mar

The George Washington University (GW) Cancer Center is pleased to announce that accomplished medical oncologist George Kim, MD, has joined the GW Cancer Center. He will serve as the director of the Gastrointestinal Cancers Program at the GW Cancer Center.


15 Mar

A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.


26 Feb

A team from the George Washington University (GW) Cancer Center has been approved for a $300,000 funding award through the Eugene Washington PCORI Engagement Awards (Engagement Awards) program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).


22 Feb

The George Washington University (GW) Cancer Center is pleased to announce the expansion of the Cutaneous Oncology Multidisciplinary Program. The program will bring together dermatologists, dermatologic surgeons, medical, surgical and radiation oncologists, and pathologists to provide personalized skin cancer care to patients in the District and surrounding region.


13 Feb

A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.


28 Jan

WASHINGTON (Jan. 28, 2018) — A team from the George Washington University (GW) Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer. The goal of this nanoimmunotherapy combination is to increase the potency of immune...


16 Jan

The George Washington University (GW) Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS, an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center...


31 Oct

WASHINGTON (Oct. 31, 2018) – Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by...